TWO PHASE EXTENSION TRIAL OF SP668 TO INVESTIGATE THE SAFETY AND TOLERABILITY OF SUSTAINED RELEASE FESOTERODINE IN SUBJECTS WITH OVERACTIVE BLADDER: A DOUBLE-BLIND PHASE FOLLOWED BY AN OPEN-LABEL EXTENSION PHASE: